A position currently open for a Pharmacy PhD post as part of the Collaborative Doctoral Award in Multimorbidity, commencing September 2018. This will involve a pilot cluster RCT of the current GP in Pharmacy project.
This is a structured doctoral training programme for a cohort of four clinical and non-clinical researchers in primary care, underpinned by the research theme of complex multimorbidity, supported by a consortium of international, experienced inter-disciplinary senior multimorbidity researchers and PhD educators. The four PhD students will participate in the HRB SPHERE Programme with parallel training in multimorbidity research, commencing in September 2018 (http://www.sphereprogramme.ie/).
Patients with complex multimorbidity (i.e. higher numbers of chronic conditions and significant polypharmacy) have poorer health outcomes and significantly higher healthcare costs. They experience treatment burden and challenges around adhering to treatment advice, managing medicines, coordination of health and social care and patient related costs of care. The proposed PhD projects will address these interlinked but distinct areas within multimorbidity research.
The Pharmacy PhD student will engage in the following projects:
PhD Project 4:
Host Institution: RCSI
Lead Supervisors, Prof Susan Smith and Dr Barbara Clyne
PhD student discipline: Pharmacy (Clinical)
Topic area: Pilot cluster RCT of the General Practice-based Pharmacist (GPP) Medicines Optimisation Programme
For further information please email Prof Susan Smith at email@example.com
[NOTE: Call for submissions now closed]
About the IIOP
The Irish Institute of Pharmacy (IIOP) manages the continuing professional development (CPD) system for pharmacists in Ireland. The Pharmaceutical Society of Ireland (PSI) has contracted the Royal College of Surgeons in Ireland (RCSI) as the management body for the IIOP.
About Practice Review
The CPD Rules  require that a sample of the patient-facing pharmacists on the PSI register be selected annually for Practice Review. The legislation stipulates that this review will encompass a “direct evaluation … of the knowledge, skills and judgement of the pharmacist, against a standard established in consultation with peer pharmacists practising in patient-facing roles, having regard to the Core Competency Framework for Pharmacists, with particular reference to those competencies dealing with patient care, including clinical knowledge, the ability to gather and interpret appropriately information from and about patients, patient management and education and communication (including counselling) skills.”
The IIOP is responsible for the management of the Practice Review process. This "direct evaluation" is achieved through standardised patient interactions (observation and evaluation of candidate pharmacist interactions with actors in clinical scenarios) and an open-book MCQ (multiple-choice question) review. Practice Review ensures that pharmacists in patient-facing roles can demonstrate a level of competence as deemed appropriate by a peer group of pharmacists. It focuses on competencies from the PSI’s Core Competency Framework. Specialist competencies are not included. The process is supportive and educational in nature, not punitive.
A Peer-Led Approach
The IIOP is committed to ensuring that this is a peer-led process and is delighted by the enthusiastic engagement of the profession in all of our activities to date.
Who Should get involved?
Pharmacists interested in getting involved should have at least three years post registration experience in a patient-facing role and be of good professional standing. The IIOP would also like to include pharmacists of mixed age and gender. No expertise in CPD, standard setting or education is required. However, previous experience in a similar role should be indicated when expressing interest. The IIOP will provide members of all groups with appropriate training and support.
Why you should get involved
Pharmacists who have been involved in practice review to-date have reported a range of benefits to being involved.
- You will work with colleagues from across the profession, which expands your network and informs you about practice in different settings
- You will learn new skills, which is interesting and contributes to your own continuing professional development
- You will be involved in setting the standard for Practice Review, which ensures that the standards that are set are peer-led
- You will contribute to your profession, which is professionally rewarding
- As a result of the interactions, pharmacists report that they become much more aware of their own practice, which helps with reflection
Quotes from pharmacists would have been involved with the process to date;
“Many thanks I really enjoyed the day and it was a great way to meet pharmacists that you might not regularly meet.”
“I was genuinely delighted to have been a part of this process, found it challenging at times yet hugely rewarding. I would be extremely interested in being involved in similar work with the Institute again after this experience”
“I really felt that I learned a lot myself and despite it being quite hard work it was thoroughly enjoyable”
“After the event I felt I missed an opportunity to get involved earlier on, but am looking forward to an opportunity in the future.”
“It was extremely enjoyable and informative and I feel confident with the whole process”
“Found the whole experience very useful”
“really interesting,glad to take part & represent my colleagues.”
What is involved?
A. Case Writing Group
What does this role involve?
Members of the Case Writing Group develop cases and multiple-choice questions, based on their practice experience. This includes cases for both the MCQ and standardised pharmacy interactions. Cases are developed with regard to the competencies dealing with patient care and clinical areas identified by the Standards Development Blueprint. Cases reflect practice scenarios ordinarily encountered by patient-facing pharmacists.
B. Case Review Group
What does this role involve?
Members of the Case Review Group will review and role play the cases developed by the Case Writing Group. This will include review for accuracy of case information, feasibility, relevance to practice and ease of evaluation.
C. Practice Reviewer Group
What does this role involve?
Members of the Practice Reviewer Group will observe and evaluate participant interactions with standardised patients (actors) in clinical scenarios.
PLEASE NOTE: All training days and workshops will take place in RCSI, Dublin. The case writing and review groups will involve a two day workshop. These workshops will be held on weekdays. The Practice Reviewer group will have a training day, and will be involved in a Practice Review event held in RCSI over a weekend in October/April.
In recognition of your work an honorarium will be payable to you.
How do I get involved?
The IIOP relies on the input of pharmacists to help shape the development of the new CPD system. Pharmacists who would like to be involved in this project should express interest by completing the online form accessed below by 14/06/2018. Following a review of applications, pharmacists will be allocated to one or more of the groups. Inclusion in the groups is based on the requirement to ensure a mix of pharmacists e.g. practice areas etc. If the number of applications exceeds the available spaces, a reserve panel will be created.
[NOTE: Call for submissions now closed]
 Pharmaceutical Society of Ireland (Continuing Professional Development) Rules 2015, S.I. 553 of 2015.
 The IIOP may proactively approach pharmacists to participate in the pilot if this mix is not achieved following the closing date for expressions of interest.
The School of Pharmacy & Pharmaceutical Sciences, Trinity College Dublin is now open to applications for the September 2018 intake of the Cardiology in Clinical Pharmacy Practice module http://pharmacy.tcd.ie/postgraduate/cardiology_clin_pharm_mod.php.
Cardiovascular disease is the leading cause of mortality and morbidity in Ireland. As a result, the Health Service Executive has placed a high priority on tackling this issue and has put a national strategy in place, with clinical care programmes specifically designed to address the key areas of concern. The aim of this module is to equip pharmacists with the requisite knowledge and skills to optimise management of cardiovascular patients in both the hospital and community settings and in doing so improve patient safety and pharmaceutical care of this patient group.
The module is open to registered community or hospital pharmacists.
Application forms and additional information are available from Niamh McMahon, Course Coordinator, email firstname.lastname@example.org; or Marian Cash, Executive Officer, email@example.com, Ph. 01-8963181 or 01-8963736 (Mon/Wed/Thurs am). Closing date: 30th June 2018.
Applications are invited for this two-year (part-time) distance learning Master’s Degree offered by the School of Pharmacy, University College Cork course, commencing in September 2018.
The course is structured to provide specialist training to enable pharmacists working in hospital and community pharmacies, extend their professional role within the evolving clinical healthcare system.
The course will develop a greater understanding of the major pharmacotherapeutic issues of various disease states in order to develop a greater understanding of the particular needs of patients with these diseases. It will also provide graduates with the skills needed to become leaders in clinical pharmacy services, such as critical appraisal of drug therapies, rational drug use (including pharmacoeconomic evaluation), medication safety management, research project management, presentation skills and report writing.
The distance learning format allows students to remain in employment throughout the course. Students will be able to communicate with each other and the teaching staff by means of regular teleconferences/webinars and interactive internet systems.
Applicants must hold a primary pharmacy degree and ideally, should have a minimum of one year practical experience. Applicants must be registered as a pharmacist with the professional accreditation authority in the country in which they are practising.
Further information about this course is available here.
Closing date for applications: 30th June 2018.
Applicants must apply online at www.pac.ie/ucc . Full details of the applicant procedure are available on this website.
For further information please contact Dr. Teresa Barbosa (Programme Director, firstname.lastname@example.org; + 353 21 490 1792), School of Pharmacy, University College Cork, Cork, Ireland.
Healthy Ireland is a major Government-led programme which aims to encourage and support everyone living in Ireland to have the best possible physical and mental health and wellbeing.
Our health is our most important asset, and we can all take some steps to improve our own health and wellbeing.
Healthy Ireland is here to help you make those positive changes and choices, to provide information and connect you with resources and organisations across the country, so you can get involved in the national effort to create a healthier Ireland.
Small changes can make a big difference to your physical and mental health and wellbeing.
We can all make positive choices such as eating healthier, being more active or minding our mental health. Click below to find more information on some small steps that can make a big difference:
Follow us on Twitter @HealthyIreland to keep up to date with what’s happening .
In recent editions of the IPU Review, the two new quality assurance components of the Continuing Professional Development (CPD) Rules 2015 (SI No 553 of 2015) for pharmacy in Ireland were profiled.
In the September 2017 Liz Hoctor, Professional Development and Learning Manager, IPU, sat down with IIOP ePortfolio Review Project Lead Katherine Morrow, to discuss some of the commonly asked questions.
You can find a copy of this article here.
In November 2017 Liz sat down with Michelle Scott, Practice Review Project Lead for IIOP, to discuss some of the questions that pharmacists might have about the new process.
You can You can find a copy of this article here.